title: Leukoencephalopathy: "Before concluding treatment efficacy...".
authors.affiliation: From the Departments of Neurology and Microbiology (D.G.), University of Colorado School of Medicine, Aurora; and Institute of Metabolic Disease (R.S.), Baylor Research Institute, Dallas. don.gilden@ucdenver.edu.
authors.forename: Don
authors.initials: D
authors.lastname: Gilden
authors.affiliation: From the Departments of Neurology and Microbiology (D.G.), University of Colorado School of Medicine, Aurora; and Institute of Metabolic Disease (R.S.), Baylor Research Institute, Dallas.
authors.forename: Raphael
authors.initials: R
authors.lastname: Schiffmann
mesh_terms: D001226:Aspartate-tRNA Ligase / Q000235:genetics*; D004660:Encephalitis / Q000503:physiopathology*; D005260:Female; D006801:Humans; D056784:Leukoencephalopathies / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*; D013256:Steroids / Q000627:therapeutic use*
chemical_list: D013256:Steroids; D001226:Aspartate-tRNA Ligase